Dr. Buthayna A. Dinary, MD

Dr. Dinary practices at Advanced Vascular Access, LLC in Cleveland, Ohio.

Dr. Dinary's NPI, 1902245087, was assigned on June 21, 2013. Dr. Dinary graduated from Odessa Medical University in 2002. Dr. Dinary holds Ohio license 35.122808.

Dr. Dinary's primary practice is Advanced Vascular Access, LLC, at 20455 Lorain Rd, Cleveland, OH 44126 in Cuyahoga County. The practice phone is (440) 799-4811.

Dr. Dinary's primary practice is Advanced Vascular Access, LLC in Cleveland, Ohio. Dr. Dinary is also affiliated with Cleveland Clinic Main Campus. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Dinary to 4 more hospitals, 3 dialysis centers, 2 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dinary practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dinary's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dinary is board certified in internal medicine by the American Board of Internal Medicine. Dr. Dinary is licensed in Ohio.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts and kidney failure among the conditions Dr. Dinary treats.

CMS data shows 1,207 Medicare services from Dr. Dinary across 8 procedure codes in 2024, for 297 Medicare patients. Medicare paid $88,483 for them.

CMS counts 297 Medicare patients who saw Dr. Dinary in 2024. The largest group is 75 to 84, with 112 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dinary's median patient age at 71, with 51% women.

In 2024, Dr. Dinary wrote 3,008 Medicare Part D claims for 335 patients. 87% of them were for generic drugs. CMS names the drug for 2,557 of them, across 57 drugs with 11 or more claims each, at $351,255 in total drug cost. In 2023, CMS named 2,284 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Dinary for performance year 2024, reported as part of a group. Dr. Dinary accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dinary as offering telehealth.

Dmand AI links 2 papers to Dr. Dinary in 2013. Dr. Dinary's most frequent co-authors are M. Chadi Alraies, MD, Naseem Eisa and Keyvan Ravakhah, MD.

CMS Open Payments shows 470 general payments to Dr. Dinary from 39 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $1,264.

Dr. Dinary graduated from Odessa Medical University in 2002. Dr. Dinary is a member of ACP.

Dr. Dinary is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.